Astellas bets on Immunomic’s allergy vaccine in a $75M deal

Damian Garde

Pharma is teaming up with biotech Immunomic Therapeutics on a that could relieve a common that affects millions in its native Japan.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS